Michele Evink is listed as a director on 1 SEC Form D filing by 1 issuer in Mar 2011: Outcomes Pharmaceutical Health Care, L.C. (West Des Moines, IA — pharmaceuticals — 2011; $188K reported sold to 1 investors).
What this means One deal on file with the SEC, filed Mar 2011. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Jim Miller (1 shared filing), Matt Osterhaus (1 shared filing), Ray Buser (1 shared filing) and Thomas Halterman (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Michele. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 1 public filing for Michele Evink and found 1 difference: Form D filed 24 days after the first sale.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.